• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腿部动脉循环障碍的治疗。在双盲试验中盐酸布他拉明作用下的肌肉测力研究]

[Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial].

作者信息

Bopp J

出版信息

Fortschr Med. 1976 Apr 22;94(12):725-7.

PMID:823084
Abstract

The extent to which a 10-day-treatment with Butalamine hydrochloride (3 X 2 tablets daily) may increase the muscular capacity in patients suffering from blood flow disorders of the lower limb was studied in a cross-over double-blind-trial. According to Fontaine comparative tests were performed with placebo and the substance in 19 patients suffering from stage II occlusion (either unilateral or bilateral). The muscular capacity in legs with blood flow disorders was found to be significantly improved by the drug compared to the placebo. Except in the case of exercise effect, the muscular capacity of the "intact" extremity however was not found to be significantly improved by the drug. Further specific studies with show whether the walking distance is improved by an increase in muscular capacity.

摘要

在一项交叉双盲试验中,研究了盐酸布他拉明(每日3次,每次2片)进行10天治疗对患有下肢血流障碍患者肌肉能力的提升程度。根据方丹分类法,对19例处于II期闭塞(单侧或双侧)的患者使用安慰剂和该药物进行了对比试验。结果发现,与安慰剂相比,该药物可显著改善存在血流障碍腿部的肌肉能力。然而,除运动效果外,该药物并未使“未患病”肢体的肌肉能力得到显著改善。进一步的具体研究将表明,肌肉能力的提升是否会增加行走距离。

相似文献

1
[Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial].[腿部动脉循环障碍的治疗。在双盲试验中盐酸布他拉明作用下的肌肉测力研究]
Fortschr Med. 1976 Apr 22;94(12):725-7.
2
[Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].[动脉闭塞性疾病的保守治疗。盐酸布他拉明疗效的双盲研究]
Fortschr Med. 1980 Feb 21;98(7):257-60.
3
[Drug therapy of chronic arterial occlusive diseases of the lower extremities with butalamine-HCl].[盐酸布他拉明治疗下肢慢性动脉闭塞性疾病]
Fortschr Med. 1979 May 17;97(19):926-8.
4
[Xenon-133 muscle clearance before and after butalamine hydrochloride. Results of a double blind test].[盐酸布他拉明前后的氙-133肌肉清除率。双盲试验结果]
Fortschr Med. 1976 Dec 2;94(34):2055-8.
5
[MR-Imaging of lower leg muscle perfusion].[小腿肌肉灌注的磁共振成像]
Herz. 2004 Feb;29(1):32-46. doi: 10.1007/s00059-004-2532-1.
6
[Drug therapy of arterial diseases. A study with Trental 400].
Fortschr Med. 1980 Dec 4;98(45):1795-8.
7
[Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].[酒石酸艾芬地尔与安慰剂治疗勒里什和方丹分类法II期下肢慢性动脉闭塞性疾病的双盲随机对照试验]
J Mal Vasc. 1995;20(1):21-7.
8
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.丙酰-L-肉碱对下肢周围动脉闭塞性疾病的影响:一项双盲临床试验。
Drugs Exp Clin Res. 1999;25(1):29-36.
9
6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.银杏叶提取物与安慰剂针对外周动脉供血不足患者进行的双盲随机临床试验,两组平行对照,为期6个月。
Arzneimittelforschung. 1984;34(6):716-20.
10
[Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)].萝巴新(新剂型)在动脉闭塞性疾病中的作用(作者译)
Med Klin. 1976 Sep 24;71(39):1605-10.